Vitos Orthopaedische Klinik Kassel gGmbH
- Address
- lock Available on a paid plan
Nervous System Diseases and Migraine Research
At Vitos Orthopaedische Klinik Kassel gGmbH, the clinical trial portfolio focuses on nervous system diseases with a strong emphasis on migraine. The studies explore both long-term prevention and acute symptom relief for people living with chronic migraine and episodic migraine.
- Evaluating new approaches for preventing migraine attacks in adults with chronic or episodic forms of the condition.
- Comparing treatments for the acute management of migraine pain and related symptoms.
- Assessing whether therapies can reduce the number of monthly migraine days and improve everyday functioning.
This research is aimed at improving both the effectiveness and tolerability of migraine care, with studies that may help refine treatment options for patients who need better prevention or faster relief.
Chronic Migraine Treatment Studies
One major area of research at this hospital clinic is chronic migraine, where trials are testing therapies designed to lower the burden of frequent headache days. The goal is to determine whether these treatments can provide meaningful prevention for patients experiencing persistent migraine symptoms.
- Testing preventive treatment options for people with chronic migraine.
- Measuring reductions in monthly migraine days as an indicator of benefit.
- Studying safety and tolerability alongside symptom control.
These studies help build evidence for better long-term management of migraine attacks with or without aura, especially for patients who need ongoing preventive care.
Episodic Migraine and Acute Relief Research
The site also conducts trials in episodic migraine, focusing on treatments that may improve how quickly and effectively migraine symptoms are relieved. Research here examines whether new options can ease pain during attacks and support patients who are unsuitable for standard therapies.
- Evaluating treatments for the acute relief of migraine headache pain.
- Comparing active therapy with placebo to measure symptom improvement.
- Exploring care options for adults with migraine with or without aura.
This work is intended to strengthen the evidence base for more flexible migraine treatment strategies, balancing symptom control with practical use in everyday clinical care.
Preventive Migraine Therapy and Long-Term Care
Research at the Kassel site includes studies of preventive therapies for both chronic and episodic migraine. These trials are designed to assess whether treatment can reduce attack frequency over time while remaining safe and well tolerated.
- Investigating long-term prevention of migraine episodes.
- Studying the impact of therapy on monthly headache burden.
- Generating evidence to support improved preventive care for migraine patients.
The focus on prevention reflects an effort to improve quality of life for people affected by recurring neurological symptoms and to expand treatment choices in a common headache disorder.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Merz Therapeutics GmbH2active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Merz Therapeutics GmbH2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Vitos Orthopaedische Klinik Kassel gGmbH
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Botulinum Toxin Type A in Chronic Migraine Prevention in Adults: A Randomized, Double-Blind, Placebo-Controlled Study | Ipsen Innovation | Phase III | Not Recruiting | Mar 2024 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins | 2 | Unknown | 2025-10-06 | 2025-10-06 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
